NYSE · Medical - Care Facilities

DaVita Inc. (DVA) Stock

$179.17 +1.21% NYSE: DVA Healthcare

Valuation

MetricValue
Price$179.17
Market Cap$11.50B
P/E Ratio15.20
P/B Ratio-14.97
P/S Ratio0.81
EPS (TTM)$9.51
52-Week High$247.49
52-Week Low$101.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-123.56%
ROA4.79%
ROCE14.20%
Gross Margin14.74%
Operating Margin14.74%
Net Margin6.05%
Debt/Equity-14.09
Current Ratio1.29

Annual Financials (USD)

Metric20212022202320242025
Revenue$11.6B$11.6B$12.1B$12.8B$13.6B
Operating Profit$1.8B$1.3B$1.6B$2.1B$2.0B
Net Profit$978.0M$560.0M$692.0M$936.0M$747.0M
EPS$8.90$5.71$7.42$10.73$9.51
Op Margin15.5%11.5%13.2%16.3%14.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.1B$16.9B$16.9B$17.3B$17.5B
Total Liabilities$14.8B$14.7B$14.2B$15.2B$16.3B
Cash$462.0M$244.0M$380.0M$795.0M$758.0M
Borrowings$12.0B$11.8B$11.1B$12.1B$15.1B

Latest News

What You Need To Know Ahead of DaVita’s Earnings Release Barchart · Jul 15, 2026 DVA: Lowering target price to $244.00 Argus Research · Jul 15, 2026 Truist Raises Price Target on DaVita to $250 From $205, Keeps Hold Rating MT Newswires · Jul 14, 2026 3 Unpopular Stocks Walking a Fine Line StockStory · Jul 14, 2026 DaVita HealthCare (DVA) Laps the Stock Market: Here's Why Zacks · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.9B$1.6B$2.1B$2.0B$1.9B
Investing Cash Flow$-1.4B$-1.2B$-1.3B$-1.3B$-1.2B
Financing Cash Flow$-1.8B$-1.1B$-635.0M$-1.9B$-2.2B
Net Cash Flow$53.0M$-216.0M$126.0M$415.0M$-122.0M
Free Cash Flow$1.3B$961.0M$1.5B$1.5B$1.3B

Valuation & Return Ratios

MetricValue
PEG Ratio1.30
EV / EBITDA7.77
FCF Yield14.18%
Quick Ratio1.41
Interest Coverage3.77
Return 1Y40.78%
Return 3Y101.36%
Return 5Y57.60%

Ownership

Insiders Held46.90%
Institutions Held52.83%
Institutions Float Held99.49%
Institutional HolderSharesReport Date
Berkshire Hathaway, Inc30,100,5852026-03-31
Blackrock Inc.2,766,7512026-03-31
Vanguard Capital Management LLC2,180,2252026-03-31
Morgan Stanley1,666,0382026-03-31
Vanguard Portfolio Management LLC1,479,6002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BAXBaxter International Inc. $24.36 +1.90% -11.46 $12.59B 0.17%
FMSFresenius Medical Care AG & Co. KGaA $23.69 -1.86% 12.64 $12.72B 3.63%
RMTIRockwell Medical, Inc. $8.07 +0.62% -6.22 $31.85M 0.00%

About DaVita Inc.

DaVita Inc. is led by CEO Javier J. Rodriguez, employs 78,000 people, headquartered in Denver, US, publicly traded since 1995.

DaVita Inc. (DVA) stock trades at $179.17 with a market capitalization of $11.50B. The stock is valued at a price-to-earnings (P/E) ratio of 15.20, price-to-book of -14.97, price-to-sales of 0.81. Over the past 52 weeks the stock has ranged between $101.00 and $247.49, and currently trades 27.6% below its 52-week high.

On profitability, DaVita Inc. generates a return on equity (ROE) of -123.56%, return on capital employed of 14.20%, an operating margin of 14.74%, a net profit margin of 6.05%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1175.60 +0.51% JNJ Johnson & Johnson $260.40 +1.53% ABBV AbbVie Inc. $276.39 +1.46% MRK Merck & Company, Inc. Common Stock (new) $146.17 +2.66% UNH UnitedHealth Group Incorporated Common Stock (DE) $382.39 +3.08% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $659.63 +1.17% AMGN Amgen Inc. $417.07 +2.36% GILD Gilead Sciences, Inc. $150.98 +2.64% ABT Abbott Laboratories $99.12 +0.64% NVO Novo Nordisk A/S $38.42 +0.62%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides